Kim R. Tsuchimoto, Chief Financial Officer at Monopar Therapeutics (MNPR), bought 325 shares at $8.00 ($3K) on 2019-12-18, disclosed to the SEC on 2019-12-20.
Open-market purchase of $3k MNPR by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| RPTP | SELL | 2012-08-31 | $18K | — | Filing → |
| RPTP | SELL | 2012-08-29 | $245 | — | Filing → |
| RPTP | SELL | 2012-06-18 | $21K | — | Filing → |